Influence of Type 1 Diabetes Mellitus on the Ocular Biometry of Chinese Children

Xiao, Ying; Li, Tao; Jia, Yan; Wang, Shanshan; Yang, Chenhao; Zou, Haidong

doi:10.1155/2019/7216490

Cited by 6 publications

(14 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Storr-Paulsen et al 3 Schultz et al 37 Busted et al 15 Keoleian et al 38 Olsen et al 16 Inoue et al 39 Larsson et al 17 Sudhir et al 40 McNamara et al 14 Ziadi et al 41 Roszkowska et al 18 Sonmez et al 42 Rosenberg et al 19 Wiemer et al 43 Lee et al 20 Beato et al 47 Su et al 21 Wang et al 54 Oriowo et al 22 Xiao et al 55 Modis et al 23 Wang et al 57 Ozdamar et al 24 Calvo-Maroto et al 25 Briggs et al 26 Sanchis-Gimeno et al 27 Altay et al 30 Kumar et al 44 Jeziorny et al 45 Luo et al 46 Ramm et al 48 Çolak et al 49 Hanyuda et al 50 Taşlı et al 51 Srećković et al 52 Suraida et al 53 Deák et al 56 Kim and Kim 58 CCT, central corneal thickness.…”

Section: Increase In Cct Values No Increase In Cct Valuesmentioning

confidence: 99%

“…Larsson et al 17 Storr-Paulsen et al 3 Lee et al 20 Busted et al 15 Calvo-Maroto et al 25 Olsen et al 16 Luo et al 46 Roszkowska et al 18 Srećković et al 52 Rosenberg et al 19 Kim and Kim. 58 Oriowo et al 22 Ozdamar et al 24 Briggs et al 26 Sanchis-Gimeno et al 27 Altay et al 30 Çolak et al 49 Xiao et al 55 conditions in Type-1 DM patients. Blood glucose levels were pharmacologically controlled in these patients.…”

Section: Andmentioning

confidence: 99%

“…McNamara et al 14 Storr-Paulsen et al 3 Su et al 21 Olsen et al 16 Modis et al 23 Roszkowska et al 18 Luo et al 46 Rosenberg et al 19 Ramm et al 48 Oriowo et al 22 Srećković et al 52 Ozdamar et al 24 Wang et al 57 Briggs et al 26 Kim and Kim 58 Sanchis-Gimeno et al 27 Altay et al 30 Çolak et al 49 Suraida et al 53 Xiao et al 55 CCT, central corneal thickness. support the theory that DM duration predisposes factors in CCT and ECD alterations.…”

Section: And Hba1c Levels Levelsmentioning

confidence: 99%

“…Other studies did not find significant differences between people with DM and control subjects. 42,43 In children, Xiao et al 55 investigated the influence of Type-1 DM on ocular biometry, and they showed that the CCT values of the healthy children were slightly higher (571.02 μm) than that of the DM children (560.29 μm); however, neither HbA1c nor DM duration was correlated with ocular biometry and CCT in the DM group. These results coincide with those of other studies such as Beato et al 47 and Wang et al 54 where control groups were found to have higher CCT values than the DM groups.…”

Section: And Hba1c Levels Levelsmentioning

confidence: 99%

See 3 more Smart Citations

Effect of diabetes mellitus on quantitative corneal anatomy – A systemic review

Sanchis‐Gimeno

Hasrod

Calvo-Maroto

et al. 2022

Afr. vis. eye health

View full text Add to dashboard Cite

Background: Corneal changes occur as a direct consequence of diabetes mellitus (DM). The central corneal thickness (CCT) is a useful parameter that provides information about the status of the metabolism of the cornea and can therefore help monitor the progression of DM.Aim: The aim of this study was to determine the impact of DM on CCT and its correlation with diabetes duration and glycated haemoglobin (HbA1c) levels.Methods: The systematic review was undertaken to answer: (1) What effect does DM have on CCT values? (2) What effect does DM duration have on CCT values? (3) What effect does HbA1c levels have on CCT values? The Web of Science was used to conduct a computerised search for articles of CCT values in DM.Results: A total of 38 articles that met the criteria for inclusion were included in this systemic review. The researchers found 27 articles that observed increased CCT values in DM patients compared with control subjects. There were six studies in which increased CCT values were related to DM duration and 12 studies in which DM duration did not alter CCT values. Also, eight studies showed that CCT values increased with glycated haemoglobin levels, and 12 studies did not observe this.Conclusion: Diabetes mellitus patients usually present with increased CCT values although there is no unanimity about the effect of DM duration and increased HbA1c levels (poor glycaemic control) in the CCT values of DM patients.

show abstract

Section: Increase In Cct Values No Increase In Cct Valuesmentioning

confidence: 99%

Section: Andmentioning

confidence: 99%

Section: And Hba1c Levels Levelsmentioning

confidence: 99%

Section: And Hba1c Levels Levelsmentioning

confidence: 99%

See 2 more Smart Citations

Effect of diabetes mellitus on quantitative corneal anatomy – A systemic review

Sanchis‐Gimeno

Hasrod

Calvo-Maroto

et al. 2022

Afr. vis. eye health

View full text Add to dashboard Cite

show abstract

“…Although China still has one of the lowest rates of T1DM in the world, in the past 20 years, the incidence of T1DM among children under the age of 15 years has nearly quadrupled, and the number of newly diagnosed adults with T1DM has increased significantly. [ 4 ] Owing to insufficient insulin production, patients must submit to multiple daily injections of insulin or continuous subcutaneous insulin injection; otherwise, blood glucose cannot be well controlled. [ 5 ] The incidence of T1DM is lower than that of type 2 diabetes mellitus (T2DM), but T1DM is more dangerous.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus

Chen

Xu²,

Zheng³

et al. 2020

Medicine

View full text Add to dashboard Cite

Background: To systematically evaluate the efficacy and safety of sotagliflozin (SOTA) adjuvant therapy for type 1 diabetes mellitus (T1DM). Methods: Through April 2019, the Web of Science, PubMed, Cochrane Library, Embase, and China National Knowledge Infrastructure databases were electronically searched to identify randomized controlled trials exploring SOTA adjuvant therapy for T1DM. Strict screening and quality evaluations of the obtained literature were performed independently by 2 researchers. Outcome indexes were extracted, and a meta-analysis of the data was performed using Revman 5.3 software. Results: A total of 7 randomized controlled trials were included. The meta-analysis results showed that compared with the patients in the placebo group, the patients in the SOTA group had a lower hemoglobin A1c (mean difference [MD] = −0.28, 95% confidence interval [CI] [−0.34, −0.22], P < .01), lower total daily insulin use (MD = −8.89, 95% CI [−11.64, −6.13], P < .01), faster weight loss (MD = −3.03, 95% CI [−3.79, −2.26], P < .01), better fasting blood glucose and 2-hour postprandial blood glucose control (MD = −0.75, 95% CI [−1.04, −0.45], P < .01; MD = −2.42, 95% CI [−3.17, −1.67], P < .01), and a higher rate of well-controlled glucose levels (relative risk = 1.75, 95% CI [1.55, 1.99], P < .01), while no significant difference in the incidence of severe hypoglycemic events was found between the SOTA and placebo groups (risk difference [RD] = −0.01, 95% CI [−0.02, 0.00], P = .13). The incidence of diabetic ketoacidosis was higher in the SOTA group than in the placebo group (RD = 0.03, 95% CI [0.02, 0.04], P < .01). The incidence of genital mycotic infection was higher in the SOTA group than in the placebo group (RD = 0.06, 95% CI [0.05, 0.08], P < .01). No significant difference in the incidence of urinary tract infections was detected between the SOTA group and the placebo group (RD = 0.00, 95% CI [−0.01, 0.01], P = 0.97). Conclusions: SOTA is a potential drug for the treatment of T1DM and is effective for controlling blood sugar. The main adverse reactions to SOTA are genital mycotic infections and diabetic ketoacidosis. We must further assess the severity of diabetic ketoacidosis caused by SOTA.

show abstract